Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis
Manjula Gunawardana(Oak Crest Institute of Science), Marc M. Baum(Oak Crest Institute of Science), Michelle L. Reyzer(Vanderbilt University), Michael Tuck(Vanderbilt University), Christopher Buser(Oak Crest Institute of Science), Martin Béliveau, Simon G. Webster(Bangor University), Craig W. Hendrix(Unknown), Amalia E. Castonguay(Oak Crest Institute of Science), Paul Webster(Unknown), Philippe Gallay(Scripps Research Institute), Mariana Remedios-Chan(Oak Crest Institute of Science), Mark A. Marzinke(Family Health International 360), Richard M. Caprioli(Vanderbilt University), Debbie Sanchez(Oak Crest Institute of Science), John A. Moss, Joseph Kuo(Scripps Research Institute), MyMy Trinh
Cited by 19
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Molecular Imaging of Biological Samples: Localization of Peptides and Proteins Using MALDI-TOF MS
|Analytical Chemistry|1997|2.2k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768